Clinical Trial Update: Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of Exenatide on abdominal fat distribution in patients with Type 2 diabetes pretreated with metformin was terminated, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2013-02-13